Analyst
Freedom Capital Markets
Equibles does not estimate personal net worth.
Gene Mannheimer is recorded as Analyst at Freedom Capital Markets. Gene Mannheimer has spoken on 8 earnings calls across 4 companies, most recently for Omnicell, Inc. on October 29, 2026. Those appearances were for Phreesia, Inc. (PHR), Omnicell, Inc. (OMCL), iRhythm Holdings, Inc. (IRTC) and Astrana Health, Inc. (ASTH). The companies whose calls Gene Mannheimer spoke on are classified in the Healthcare sector.
“Just going back to the discussion around leases, do the lease conversations tend to be concentrated more to smaller health systems or not necessarily?”
“I guess my question is, regarding competitive opportunities, how does the percent of competitive conversions in your pipeline compare to that of the XT cycle 9, 10 years ago?”
“Thanks for taking the question, and congrats on a good start to 2026. so coming in or tracking to the high end of cost synergies with prospect can you discuss potential revenue synergies there and when when you you may start to see that realized and my follow-up would be you know on the mlr trends at or better than…”
“You know, along some of the lines that were discussed, you know, kind of running ahead of guidance and raising it, have you contemplated any change to your long-term financial targets?”
“Just thinking about your prepared remarks, you know, you're holding the EBITDA guidance steady despite the revenue reduction. And I understand about the continuing margin expansion and efficiencies that you're driving.”
Freedom Capital Markets
Analyst
Transcript header (unverified)
PHR
Health Information Services · Healthcare
OMCL
Health Information Services · Healthcare
ASTH
Medical Care Facilities · Healthcare
